Steve Tutewohl
Net Worth

Last updated:

What is Steve Tutewohl net worth?

The estimated net worth of Mr. Steve Tutewohl is at least $6,582,128 as of 3 Mar 2022. He owns shares worth $976,873 as insider, has earned $1,245,255 from insider trading and has received compensation worth at least $4,360,000 in Evolent Health, Inc..

What is the salary of Steve Tutewohl?

Mr. Steve Tutewohl salary is $1,090,000 per year as Chief Operating Officer in Evolent Health, Inc..

How old is Steve Tutewohl?

Mr. Steve Tutewohl is 52 years old, born in 1973.

What stocks does Steve Tutewohl currently own?

As insider, Mr. Steve Tutewohl owns shares in one company:

Company Title Shares Price per share Total value
Evolent Health, Inc. (EVH) Chief Operating Officer 108,421 $9.01 $976,873

What does Evolent Health, Inc. do?

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Steve Tutewohl insider trading

Evolent Health, Inc.

Mr. Steve Tutewohl has made 11 insider trades between 2021-2022, according to the Form 4 filled with the SEC. Most recently he sold 1,918 units of EVH stock worth $52,361 on 3 Mar 2022.

The largest trade he's ever made was exercising 25,030 units of EVH stock on 3 Aug 2021. As of 3 Mar 2022 he still owns at least 108,421 units of EVH stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Class A Common Stock 1,918 $27.3 $52,361
Option
Class A Common Stock Option (right to buy) 5,388 $13.29 $71,607
Sale
Class A Common Stock 5,388 $27.41 $147,685
Option
Class A Common Stock 5,388 $13.29 $71,607
Sale
Class A Common Stock 1,707 $22.85 $39,005
Sale
Class A Common Stock 6,313 $23.47 $148,166
Option
Class A Common Stock 6,313 $13.95 $88,066
Option
Class A Common Stock Option (right to buy) 6,313 $13.95 $88,066
Sale
Class A Common Stock 13,553 $25.05 $339,503
Option
Class A Common Stock Option (right to buy) 25,030 $23.02 $576,191
Sale
Class A Common Stock 11,229 $23.02 $258,492
Option
Class A Common Stock 25,030 $23.02 $576,191
Option
Class A Common Stock Option (right to buy) 5,956 $18.49 $110,097
Option
Class A Common Stock 5,956 $18.49 $110,097
Sale
Class A Common Stock 3,331 $13.95 $46,467
Option
Class A Common Stock Option (right to buy) 13,849 N/A N/A
Option
Class A Common Stock Option (right to buy) 13,849 $19.76 $273,698
Option
Class A Common Stock 13,849 N/A N/A
Option
Class A Common Stock 13,849 $19.76 $273,698
Sale
Class A Common Stock 10,576 N/A N/A
Option
Class A Common Stock 200 N/A N/A
Sale
Class A Common Stock 200 N/A N/A
Option
Class A Common Stock Option (right to buy) 200 N/A N/A
Option
Class A Common Stock 9,352 N/A N/A
Sale
Class A Common Stock 9,352 N/A N/A
Option
Class A Common Stock Option (right to buy) 9,352 N/A N/A
Option
Class A Common Stock Option (right to buy) 9,352 $7.83 $73,226
Sale
Class A Common Stock 9,943 $21.48 $213,576
Option
Class A Common Stock 9,352 $7.83 $73,226

Evolent Health key executives

Evolent Health, Inc. executives and other stock owners filed with the SEC: